These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6446978)

  • 1. [Contribution to the experimental Serratia marcescens infection (author's transl)].
    Tichácek B
    Cesk Epidemiol Mikrobiol Imunol; 1980 Mar; 29(2):74-82. PubMed ID: 6446978
    [No Abstract]   [Full Text] [Related]  

  • 2. [The study of selected factors of virulence in Serratia marcescens (author's transl)].
    Tichácek B
    Cesk Epidemiol Mikrobiol Imunol; 1982 Jan; 31(1):55-63. PubMed ID: 6460566
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution to the investigation of mixed experimental infections (author's transl)].
    Tichácek B
    Cesk Epidemiol Mikrobiol Imunol; 1981 Nov; 30(6):321-7. PubMed ID: 6459163
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serratia marcescens in bovine mastitis. Bibliography and a case study (author's transl)].
    Lium ER
    Nord Vet Med; 1977 Dec; 29(12):529-32. PubMed ID: 341073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serratia marcescens ("B. prodigiosus"), the germ of hospital infections].
    Modde H
    Rev Med Suisse Romande; 1974 Apr; 94(4):325-32. PubMed ID: 4596928
    [No Abstract]   [Full Text] [Related]  

  • 7. Study on pathogenicity, drug sensitivity and pigment production of Serratia marcescens.
    Wu KH
    Taiwan Yi Xue Hui Za Zhi; 1976 Feb; 75(2):120-9. PubMed ID: 787472
    [No Abstract]   [Full Text] [Related]  

  • 8. Methods to determine antipathogenic potential of phenolic and flavonoid compounds against urinary pathogen Serratia marcescens.
    Annapoorani A; Parameswari R; Pandian SK; Ravi AV
    J Microbiol Methods; 2012 Oct; 91(1):208-11. PubMed ID: 22759832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on serotyping, phage typing and drug resistance of Serratia marcescens isolated from clinical specimens (author's transl)].
    Morishita H
    Nihon Hinyokika Gakkai Zasshi; 1980 Nov; 71(11):1313-27. PubMed ID: 7007698
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hospital infection due to Serratia marcescens and its sensitivity to antibiotics].
    Filloy L; Serrano D; Borjas E
    Bol Med Hosp Infant Mex; 1980; 37(5):871-7. PubMed ID: 7000092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serratia marcescens: biochemical characteristics, antimicrobial sensitivity and clinical significance.
    Puthucheary SD; Ngeow YF
    Malays J Pathol; 1981 Aug; 4():35-41. PubMed ID: 6764658
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies of lipase and antilipase on different strains of the genera Serratia, Aeromonas and Vibrio (author's transl)].
    Caselitz FH; Freitag V; Meyer HJ
    Zentralbl Bakteriol A; 1980 Mar; 246(3):336-43. PubMed ID: 6999789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of Serratia marcescens in a hospital.
    Sekiguchi J; Fujino T; Kuroda E; Konosaki H; Nishimura H; Saruta K; Kawana A; Yamanishi F; Kudo K; Kondo T; Yazaki Y; Kuratsuji T; Kirikae T
    Jpn J Infect Dis; 2004 Apr; 57(2):78-80. PubMed ID: 15118217
    [No Abstract]   [Full Text] [Related]  

  • 14. SME-2-producing Serratia marcescens isolate from Switzerland.
    Poirel L; Wenger A; Bille J; Bernabeu S; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2282-3. PubMed ID: 17420208
    [No Abstract]   [Full Text] [Related]  

  • 15. Bleaching of Serratia marcescens by some coumarins: a spectrophotometric study.
    Shahverdi AR; Mirjani R; Amin G; Shafiee A; Iranshahi M
    J Basic Microbiol; 2005; 45(6):470-4. PubMed ID: 16304709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of the speed of bactericidal activity of cephalosporin and other antibiotics on Serratia marcescens strains isolated from an epidemic focus].
    Michelone G; Perversi L; Verani DA; Marone P; Concia E
    G Ital Chemioter; 1982; 29(2):103-7. PubMed ID: 6764625
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serratia marcescens (author's transl)].
    Tichácek B
    Cesk Epidemiol Mikrobiol Imunol; 1979 Sep; 28(5):310-20. PubMed ID: 161519
    [No Abstract]   [Full Text] [Related]  

  • 18. Serratia marcescens prosthesis infection successfully treated with meropenem after imipenem failure.
    Lefort A; Righi S; Jauréguy F; Bégué T; Robineau M; Bouchaud O; Lortholary O
    J Infect; 2005 Aug; 51(2):E45-7. PubMed ID: 16038749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility of nonpigmented Serratia marcescens.
    Thornton GF; Cramer JA
    Antimicrob Agents Chemother (Bethesda); 1970; 10():514-6. PubMed ID: 4939745
    [No Abstract]   [Full Text] [Related]  

  • 20. A bacteriological study of non-chromogenic variants of Serratia marcescens from human sources.
    Elston HR
    J Clin Pathol; 1965 Sep; 18(5):618-21. PubMed ID: 5319719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.